Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

1269243

USP

Famotidin-verwandte Verbindung D

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

3-{{{2-[(Diaminomethylen)-amino]-thiazol-4-yl}-methyl}-sulphanyl}-propanamid, 3-[[[2-[(Aminoiminomethyl)-amino]-4-thiazolyl]-methyl]-thio]-propanamid

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C8H13N5OS2
CAS-Nummer:
76824-16-3
Molekulargewicht:
259.35
UNSPSC-Code:
41116107
NACRES:
NA.24

Biologische Quelle

synthetic

Qualität

pharmaceutical primary standard

Agentur

USP

API-Familie

famotidine

Form

powder

Verpackung

pkg of 25 mg

Hersteller/Markenname

USP

Lagerbedingungen

protect from light

Farbe

white

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

InChI

1S/C8H13N5OS2/c9-7(14)1-2-15-3-6-4-16-8(13-6)11-5-12-10/h4-5H,1-3,10H2,(H2,9,14)(H,11,12,13)

InChIKey

ASHSLSDRNNWQKI-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Famotidine Related Compound D (Famotidine Impurity D) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Famotidine Related Compound D can be used as a pharmaceutical primary standard for the determination of the analyte in pharmaceutical formulations by various analytical techniques.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1055

Famotidin, Pharmaceutical Secondary Standard; Certified Reference Material

F0005000

Famotidin, European Pharmacopoeia (EP) Reference Standard

Y0000409

Famotidin Unreinheit D, European Pharmacopoeia (EP) Reference Standard

Y0000382

Famotidin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

1269200

Famotidin, United States Pharmacopeia (USP) Reference Standard

1269265

Famotidine-verwandte Verbindung F, United States Pharmacopeia (USP) Reference Standard

1269221

Famotidin-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1269232

Famotidin-verwandte Verbindung C, United States Pharmacopeia (USP) Reference Standard

1269254

Famotidin-verwandte Verbindung E, United States Pharmacopeia (USP) Reference Standard

BP653

Famotidin, British Pharmacopoeia (BP) Reference Standard

PHR2908

Famotidin-verwandte Verbindung F, certified reference material, pharmaceutical secondary standard

PHR2909

Famotidin-verwandte Verbindung B, certified reference material, pharmaceutical secondary standard

PHR2910

Famotidin-verwandte Verbindung C

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
Helali N and Monser L
Journal of Separation Science, 31(2) (2008)
Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
Helali N, et al.
Talanta, 74(4) (2008)
Famotidine
Pharmacopeia, US
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Potentiometric determination of famotidine in pharmaceutical formulations
Ayad MM, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Helali N, et al.
Chromatographia, 60(7-8) (2004)

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.